Abstract: An implantable anchor for anchoring a lead or catheter relative to biological tissue, implantable system including such an anchor and a lead or catheter, and a method of use of such anchor. The anchor comprises a body having a channel adapted to receive a catheter or lead, and a cover mounted on the body for pivoting motion along a lateral axis, that is an axis that extends generally in the lateral direction perpendicular to the catheter or lead, between an open position in which the anchor is adapted to allow a lead or catheter to be placed in or moved along the channel, and a locked position in which the anchor is adapted to retain a lead or catheter within the channel.

Abstract: Methods and devices for initializing templates for evoked response detection from pacing stimulation are described. A method of generating templates characterizing a cardiac response to pacing involves determining values associated with signal features for each of a number of sensed cardiac signals following pacing pulses. The median values of the features are used to generate a cardiac response template.

Abstract: A medical device system and method for delivering mechanically fused left ventricular cardiac stimulation. A sensor monitors left ventricular acceleration while left ventricular cardiac stimulation is provided at an AV interval. The left ventricular acceleration is used to calculate a mechanical response interval and the mechanical response interval is compared to a desired mechanical response interval. The AV interval is adjusted until the mechanical response interval is equal to the desired mechanical response interval.

Abstract: An implantable cardiac device includes a housing (2), pulse generator (7) therein to generate physiologically effective electrical pulses, a shock lead (3), externally of the housing (2), connectable to the pulse generator (7) and implantable into a patient's body to apply physiologically effective electrical pulses to the patient's body, a monitor (8) to automatically detect a lead condition as to whether the shock lead (3) is implanted or not, and control (9), which due to the detected lead condition automatically enables or disables the pulse generator (7).

Abstract: Therapy and treatment devices, systems and methods for providing tactile and electrical stimulation to augment mammary glands and for making the tissues healthy and anti-carcinogenous. The devices, systems and methods combine both massage (tactile) stimulation with electrical current stimulation by electrodes to both augment mammary glands and for making the tissues healthy and anti-carcinogenous.

Abstract: An implantable medical device identifies onset and/or progression of left ventricular dysfunction (LVD). The implantable medical device receives a signal that represents electrical activity within a heart, e.g., an electrogram signal, and digitally processes the signal to assess left ventricular function. In particular, the implantable medical device measures at least one characteristic of QRS complexes within the signal, and assesses left ventricular function based on measurements. The implantable medical device may, for example, measure the width of the QRS complexes and/or the amplitude of the R-waves within the QRS complexes. The implantable medical device may alert a patient or clinician of the onset or progression of LVD, and may control delivery of therapies, such as rate-responsive pacing and cardiac resynchronization pacing, based on the measurements. The implantable medical device may also control delivery of a drug by an implanted drug delivery device, e.g., drug pump, based on the measurements.

Abstract: In an implantable medical device that provides atrial and ventricular pacing in an atrial-based pacing mode, longer periods of time are permitted for intrinsic AV conduction to occur. By monitoring the patient's AV delay under these circumstances, useful information is obtained that can be correlated to other patient conditions or symptoms.

Abstract: Exemplary cochlear implant systems include an implantable cochlear stimulator configured to be implanted within a patient and generate a stimulation current having an adjustable current level, one or more electrodes communicatively coupled to the stimulator and configured to apply the stimulation current to one or more locations within an ear of the patient, and a sound processor configured to derive an acoustic reflectance of the patient's ear. The implantable cochlear stimulator is configured to adjust the current level of the stimulation current until the sound processor detects a change in the acoustic reflectance above a threshold.

Abstract: An aerobic spa system comprising a water source providing water, an ozone source providing ozone, an ozone introduction mechanism adapted to introduce at least some of the ozone into the water, an ozone saturation mechanism adapted to cause at least some of the ozone to be dissolved into the water, a substantially enclosed chamber receiving water containing dissolved ozone; and a user at least partially disposed inside the chamber who comes into contact with the water containing dissolved ozone.

Abstract: Methods of detecting an error associated with an implantable device include powering up the implantable device with an external device, disabling a back-telemetry transmitter within the implanted device after the implanted device is powered up, detecting an error with the implanted device, generating a fault signal corresponding to the error with the implanted device, turning on the back-telemetry transmitter after the fault signal has been generated, and transmitting the fault signal to the external device with the back-telemetry transmitter.

Abstract: A lead assembly includes a ring component having mechanical coupling features, and at least one polymer component mechanically coupled with the mechanical coupling features of the ring component. Elongate tubing is disposed over the polymer component and is secured with the polymer component.

Abstract: Medical device and methods are provided for controlled drug delivery in a cardiac patient. The device includes an implantable drug delivery module comprising reservoirs containing a drug and a control means for selectively releasing an effective amount of drug from each reservoir; one or more electrodes or sensors for cardiac monitoring, stimulation, or both; and a microcontroller for controlling operational interaction of the drug delivery module and the cardiac electrode. The electrodes may comprise ECG monitoring, cardioversion, or cardiac pacing electrodes.

Abstract: Tachyarrhythmia is treated by applying anti-tachycardia pacing through at least one multi-site electrode set located on, in or around the heart. The electrode set is arranged and located such that an electrical activation pattern having a wave-front between substantially flat and concave is generated through a reentrant circuit associated with the tachyarrhythmia. The electrode set may be one of a plurality of predefined, multi-site electrode sets located on, in or around the atria. Alternatively, the electrode set may be formed using at least two selectable electrodes located on, in or around the atria.

Abstract: Housing for medical implant, such as cardiac pacemaker, defibrillator, cardioverter, etc. Housing including hollow housing and terminal body attached to hollow housing, which has electrical terminal(s), situated in an externally accessible cavity of the terminal body, for connecting an electrode line, and terminal body including a base body made of electrically insulating plastic, connected to hollow housing and carries electrical supply lines and electrical contacts, which are electrically connected thereto, for the electrical terminal so that the contacts are connected via the electrical supply lines to electrical components in the interior of the hollow housing, electrical supply lines being welded to the electrical contacts and the electrical supply lines and electrical contacts, which are welded to one another, being embedded in the base body and thus fixed in their final position, and the base body being glued to the hollow housing using an adhesive between hollow housing and terminal body.

Abstract: Methods and devices for fitting a visual prosthesis are described. In one of the methods, threshold levels and maximum levels for the electrodes of the prosthesis are determined and a map of brightness to electrode stimulation levels is later formed. A fitting system for a visual prosthesis is also discussed, together with a computer-operated system having a graphical user interface showing visual prosthesis diagnostic screens and visual prosthesis configuration screens.

Abstract: In an implantable pacemaker, pacing pulses are delivered to a ventricle in a P-wave synchronous mode as long as no atrial arrhythmia is detected, pacing pulses and a mode switch is made to deliver pacing pulses to the ventricle in a non-P-wave synchronous mode if atrial arrhythmia is detected. From an impedance signal measured in the atrium, atrial distention is determined and, in the non-P-wave synchronous mode, the delivery rate of the pacing pulses is increased to decrease the atrial distention during atrial arrhythmia.

Abstract: An electrode array has a flexible body supporting a plurality of electrodes. Each electrode comprises an exposed connector pad at the upper end of the body, an exposed recording/stimulating pad at the lower end of the body, and a conductor located within the body and electrically connecting the connector pad and the recording/stimulating pad. In one embodiment the electrode array has an elongated recording/stimulating portion coiled or folded to distribute the exposed recording/stimulating pads in three dimensions. An implantation method employs an introducer with a helical portion to which an end of the flexible electrode is attached. The helical portion straightens to pass through a small-diameter cannula and then resumes its helical configuration to place the recording/stimulating portion of the attached electrode in a helix within the patient's tissues.

Abstract: An implantable lead assembly includes a lead body extending from a proximal end to a distal end having an intermediate portion therebetween, where the lead body includes an insulating layer. A conductor is disposed within the insulating layer and the insulating layer surrounds the conductor. An electrode is coupled to the lead body, and the electrode is in electrical communication with the conductor. At least one conductive sleeve is disposed within the insulating layer. The at least one conductive sleeve surrounds the conductor and is electrically isolated from the electrode. The at least one conductive sleeve has a first impedance value in a first condition.

Abstract: A pair of functional metal ion bands are provided. The pair of functional metal ion bands are attached to meridians and acupoints of the human body in a simple manner to induce a smooth flow of current in the body, thereby rapidly changing a disease condition to a normal state. The pair of functional metal ion bands comprise a gold-colored thin metal plate as a positive electrode and a silver-colored thin metal plate as a negative electrode wherein the gold-colored thin metal plate is composed of Cu and a metal selected from Ag, Au and Pt and the silver-colored thin metal plate is made of an alloy of Al, Si, Fe, Cu, Mn, Mg and Zn. The pair of functional metal ion bands are manufactured by processing each of the thin metal plates to have a thickness of 1 ?m to 1 cm and a diameter of 1 mm to 50 cm, and attaching the processed metal plate to one side of a soft adhesive fabric using an adhesive.

Abstract: In some embodiments, an implantable medical device (IMD) system may include one or more of the following elements: (a) an oxygen sensor for measuring oxygen extraction from blood flowing through a coronary sinus of a patient's heart, (b) an oxygen signal generated by the oxygen sensor, (c) an IMD coupled to the oxygen sensor, wherein the IMD is configured to output pacing pulses as a function of the oxygen signal, and (d) an atrial and a ventricular pacing lead coupled to the IMD to deliver the pacing pulses to the patient's heart, wherein the IMD generates the pacing pulses as a function of the oxygen signal, wherein the pacing pulses are adjusted by the IMD as a function of the oxygen signal, wherein the IMD is configured to adjust the pacing pulses to increase oxygen in the blood flow through the coronary sinus.